Synthesis of (23R)- and (23S)-23H-Isocalysterols
FULL PAPER
layer was extracted with further diethyl ether. The combined or-
ganic extracts were washed with satd. aq. NH4Cl solution, the solv-
ent was evaporated, and the residue was chromatographed on SiO2
(10–40 µm, Merck 7736, 24 g). Fractions were collected as follows:
(5 mL). The aqueous layer was extracted with further diethyl ether
and the combined organic extracts were washed with satd. aq.
NaHCO3 solution. The solvent was then evaporated and the res-
idue was chromatographed on SiO2 (0.5 g, hexane/diethyl ether,
elution with hexane gave 23 (58 mg, 12%); elution with hexane/ 100:1) to give the calysterol derivative 18b (12 mg, 53%). – 1H
CH2Cl2, 8:1, gave 24 (76 mg, 13%), followed by (23S,24R)-15c
NMR: δ ϭ 0.43 (dd, J ϭ 8.0, 5.0 Hz, 1 H, 4α-H), 0.65 (t, J ϭ
(22 mg), a mixture of 15c and 15d (190 mg), and (23R,24S)-15d 4.4 Hz, 1 H, 4β-H), 0.72 (s, 3 H, 18-H), 0.98–1.14 (d, J ϭ 7.0 Hz,
(15 mg). The chromatography was monitored by TLC (hexane/
CH2Cl2, 2:1, developed 3 times). The combined yield of 15c and
15d amounted to 50%. The mixture of products was also separated
by preparative HPLC on a Macherey–Nagel Duren Nucleosil
100–10 C18 column eluting with hexane/CH2Cl2, 3:1, flow rate
8 mL/min., UV detection at λ ϭ 235 nm.
3 H, 21-H coincident with s, 3 H, 19-H), 1.10 (d, J ϭ 6.9 Hz, 3 H,
26-H), 1.12 (d, J ϭ 6.9 Hz, 3 H, 27-H), 2.02 (d, J ϭ 1.6 Hz, 3 H,
29-H), 2.63 (sept q, J ϭ 6.8, 1.6 Hz, 1 H, 25-H), 2.74–2.81 (m, 1
H, 6-H), 3.32 (s, 3 H, CH3O). – MS: m/z (%) ϭ 424 [Mϩ] (2), 409
[Mϩ – Me] (3), 392 [Mϩ – CH3OH] (3), 381 [Mϩ – CH(CH3)2] (7),
377 [Mϩ – CH3 – CH3OH] (2), 369 [Mϩ – C4H7] (5), 349 [Mϩ
–
CH(CH3)2 – CH3OH] (2), 283 (10), 253 [Mϩ – side chain –
CH3OH – 2 H] (100), 227 (8), 213 (9), 199 (8), 187 (8), 173 (10),
159 (18), 155 (12), 143 (12), 121 (17), 109 (17), 95 (35), 91 (12), 77
(12), 65 (10), 51 (5). – C30H48O: calcd. 424.3705; found 424.3707
(MS).
(23R*,24S*)-3β,24-Dibromo-23,24-(dibromomethylene)cholest-5-ene
(23) (Mixture of Diastereoisomers): 1H NMR: δ ϭ 0.70 and 0.73
(s, 3 H, 18-H), 1.04 (s, 3 H, 19-H), 1.09 (d, J ϭ 6.5 Hz, 27- and 21-
H), 1.10 (d, J ϭ 6.6 Hz, 26- and 21-H), 1.17 (d, J ϭ 6.4 Hz, 3 H,
27-H), 3.80–4.05 (m, 1 H, CHBr), 5.30–5.42 (m, 1 H, CϭCH). –
MS: m/z (%) ϭ 702, 700, 698, 696, 694 [Mϩ] (6), 687, 685, 683,
681, 679 [Mϩ – CH3] (8), 621, 619, 617, 615 [Mϩ – Br] (100), 365,
363 [Mϩ – C7H10Br3] (57), 335, 333 (77), 295, 293 (25), 241, 239,
237 (27), 229, 227, 225, 223 (25), 215, 213 (42).
(23S)-23H-Isocalysterol [(23S)-23,28-Cyclostigmasta-5,24(28)-dien-
3β-ol] (2b): A mixture of i-steroid 18b (12 mg, 0.028 mmol), dioxane
(1 mL), water (250 µL), and TsOH (1 mg) was stirred at 80 °C for
1 h, cooled to room temp., and then partitioned between diethyl
ether (3 mL) and satd. aq. NaHCO3 solution (2 mL). The aqueous
layer was extracted with further diethyl ether and the combined
organic extracts were washed with brine. The solvent was then
evaporated and the residue was chromatographed on a column
packed with silica gel for TLC (10–40 µm, Merck 7736) eluting
with hexane/diethyl ether, 15:1, to give isocalysterol 2b (3.6 mg,
31%) and 2b contaminated with a UV light-absorbing substance
(23R*,24S*)-24-Bromo-6α-dibromomethyl-23,24-dibromomethylene-
1
6β-methoxy-3α,5-cyclo-5α-cholestane (24): – H NMR: δ ϭ 0.78 (s,
3 H, 18-H), 1.06–1.12 (s, 3 H, 19-H coincident with d, 3 H, 21-H),
1.10 (d, J ϭ 6.3 Hz, 3 H, 26-H), 1.18 (d, 3 H, J ϭ 6.0 Hz, 27-H),
3.31 (s, 3 H, CH3O), 5.75 (s, 1 H, CHBr2). – MS: m/z (%) ϭ 824,
822, 820, 818, 816, 814 [Mϩ] (3), 712, 710, 708, 706, 704 [Mϩ
–
Br – CH3OH] (97), 651, 649, 647, 645 [Mϩ – CHBr2] (100), 628
[Mϩ – Br2 – CH3OH] (88), 617, 615, 613, 611, 609 [C22H29Br4]
(44), 549, 547, 545 [Mϩ – Br3 – CH3OH] (20). – LSIMS (with
NaOAc): m/z (%) ϭ 849, 847, 845, 843, 841, 839 [M ϩ Na]ϩ (37),
651, 649, 647, 645 [Mϩ – CHBr2] (100).
(2.8 mg). An analytical sample was obtained by HPLC (tR
18.25 min). Its H-NMR and mass spectra were identical to those
of a sample obtained as described above.
ϭ
1
(23R,24S)-24-Bromo-23,24-(dibromomethylene)cholest-5-en-3β-ol
(17d): A mixture of i-steroid 15d (40 mg, 0.062 mmol), dioxane
(1.6 mL), water (250 µL), and TsOH (1 mg) was stirred at 81–84
°C for 30 min., allowed to cool to room temp., and then partitioned
between diethyl ether and satd. aq. NaHCO3 solution. The aqueous
layer was extracted with further diethyl ether and the combined
organic extracts were concentrated to dryness. The residue was
chromatographed on SiO2 (1 g; hexane/diethyl ether, 6:1) to yield
alcohol 17d (37.7 mg, 96%). An analytical sample was obtained by
crystallization from hexane; m.p. 132–135 °C and 149–152 °C. –
1H NMR: δ ϭ 0.73 (s, 3 H, 18-H), 1.01 (s, 3 H, 19-H), 1.09 (d,
J ϭ 6.6 Hz, 3 H, 21-H or 26-H), 1.10 (d, J ϭ 6.6 Hz, 3 H, 21-H
or 26-H), 1.18 (d, J ϭ 6.4 Hz, 3 H, 27-H), 3.40–3.65 (m, 1 H, 3-
H), 5.30–5.40 (m, 1 H, 6-H). – C28H43OBr3 (635.35): calcd. C 52.93,
H 6.82; found C 53.00, H 6.94.
(23S,24R)-24-Bromo-23,24-dibromomethylene-6β-methoxy-3α,5-
cyclo-5α-cholestane (15c): Rf ϭ 0.44, tR ϭ 39.18 min. – H NMR:
1
δ ϭ 0.43 (dd, J ϭ 7.9, 5.1 Hz, 1 H, 4α-H), 0.65 (t, J ϭ 4.9 Hz, 1
H, 4β-H), 0.74 (s, 3 H, 18-H), 1.03 (s, 3 H, 19-H), 1.09 (d, 3 H,
J ϭ 5.6 Hz, 21-H), 1.09 (d, 3 H, J ϭ 6.6 Hz, 26-H), 1.18 (d, J ϭ
6.4 Hz, 3 H, 27-H), 2.74–2.81 (m, 1 H, 6-H), 3.32 (s, 3 H, CH3O). –
MS: m/z (%) ϭ 652, 650, 648, 646 [Mϩ] (51), 637, 635, 633, 631
[Mϩ – Me] (54), 620, 618, 616, 614 [Mϩ – CH3OH] (69), 597, 595,
593, 591 [Mϩ – C4H7] (100), 553 (11). – C29H45OBr3: calcd.
646.102048; found 646.101578 (MS).
(23R,24S)-24-Bromo-23,24-dibromomethylene-6β-methoxy-3α,5-
1
cyclo-5α-cholestane (15d): Rf ϭ 0.41, tR ϭ 43.24 min. – H NMR:
δ ϭ 0.43 (dd, J ϭ 7.9, 5.4 Hz, 1 H, 4α-H), 0.65 (t, J ϭ 4.4 Hz, 1
H, 4β-H), 0.79 (s, 3 H, 18-H), 1.03 (s, 3 H, 19-H), 1.09 (d, 3 H,
J ϭ 6.6 Hz, 21-H), 1.10 (d, J ϭ 6.6 Hz, 3 H, 26-H), 1.18 (d, J ϭ
6.5 Hz, 3 H, 27-H), 2.73–2.80 (m, 1 H, 6-H), 3.33 (s, 3 H, CH3O). –
MS: m/z (%) ϭ 652, 650, 648, 646 [Mϩ] (50), 637, 635, 633, 631
[Mϩ – Me] (56), 620, 618, 616, 614 [Mϩ – CH3OH] (67), 597, 595,
593, 591 [Mϩ – C4H7] (100), 553 (9). – C29H45Br3O: calcd.
646.10205; found 646.10222 (MS).
(23S,24R)-24-Bromo-23,24-(dibromomethylene)cholest-5-en-3β-ol
(17c): A mixture of i-steroid 15c (33 mg, 0.051 mmol), dioxane
(1 mL), water (250 µL), and TsOH (1 mg) was stirred at 85 °C for
2 h, then allowed to cool, and worked-up as described above to
1
give alcohol 17c (31 mg, 95%). – H NMR: δ ϭ 0.71 (s, 3 H, 18-
H), 1.01 (s, 3 H, 19-H), 1.09 (d, J ϭ 6.5 Hz, 6 H, 26- and 27-H or
26- and 21-H), 1.17 (d, J ϭ 6.5 Hz, 3 H, 21-H or 27-H), 3.40–3.65
(m, 1 H, 3-H), 5.30–5.40 (m, 1 H, 6-H). – MS: m/z (%) ϭ 638, 636,
634, 632 [Mϩ] (8), 539, 537, 535 [Mϩ – Br – H2O] (15), 283 (21),
271, 253, 213 (27), 199 (15). – C28H43OBr3: calcd. 632.0864; found
632.0863 (MS).
(23S)-6β-Methoxy-3α,5:23,28-dicyclo-5α-stigmasta-24(28)-ene
(18b): To a stirred solution of (23R,24S)-tribromide 15d (34 mg,
0.053 mmol) in diethyl ether (0.5 mL), MeLi (1.45 in diethyl
ether, 146 µL, 0.212 mmol) was added at –78 °C. The resulting
mixture was allowed to warm to room temp., then cooled to –65
°C, whereupon MeI (100 µL, 1.6 mmol) was added. The cooling
bath was then removed and, after 2.5 h, the mixture was parti-
(23R)-23H-Isocalysterol [(23R)-23,28-Cyclostigmasta-5,24(28)-dien-
3β-ol] (2a): To a solution of 17c (24.5 mg, 0.04 mmol) in CH2Cl2
tioned between diethyl ether (5 mL) and satd. aq. NH4Cl solution (1 mL), 2-methoxypropene (16 µL, 0.16 mmol) and Amberlyst-15H
Eur. J. Org. Chem. 2000, 1027Ϫ1036 1035